Oxford BioTherapeutics

6 open jobs

Oxford BioTherapeutics is a clinical-stage biotechnology company focusing on the development of antibody therapeutics for the treatment of cancer. The company uses its OGAP-verify® platform, the world's largest cancer-specific membrane protein library, to identify novel tumor-specific antigens for ADC, T-cell Engager, and CAR-T targets. Its pipeline includes internal programs focused on ADCs and checkpoint regulators, as well as partnerships with companies like Roche, GSK, and Zymeworks.